Targeted sequencing and in vitro splice assays shed light on ABCA4-associated retinopathies missing heritability.
Journal
HGG advances
ISSN: 2666-2477
Titre abrégé: HGG Adv
Pays: United States
ID NLM: 101772885
Informations de publication
Date de publication:
12 Sep 2023
12 Sep 2023
Historique:
received:
05
06
2023
revised:
07
09
2023
accepted:
08
09
2023
medline:
14
9
2023
pubmed:
14
9
2023
entrez:
14
9
2023
Statut:
aheadofprint
Résumé
The ABCA4 gene is the most frequently mutated Mendelian retinopathy-associated gene. Biallelic variants lead to a variety of phenotypes, however, for thousands of cases the underlying variants remain unknown. Here, we aim to shed further light on the missing heritability of ABCA4-associated retinopathy by analyzing a large cohort of macular dystrophy probands. A total of 858 probands were collected from 26 centers, of whom 722 carried no or one pathogenic ABCA4 variant while 136 cases carried two ABCA4 alleles, one of which was a frequent mild variant, suggesting that deep-intronic variants (DIVs) or other cis-modifiers might have been missed. After single molecule molecular inversion probes (smMIPs)-based sequencing of the complete 128-kb ABCA4 locus, the effect of putative splice variants was assessed in vitro by midigene splice assays in HEK293T cells. The breakpoints of copy number variants (CNVs) were determined by junction PCR and Sanger sequencing. ABCA4 sequence analysis solved 207/520 (39.8%) naïve or unsolved cases and 70/202 (34.7%) monoallelic cases, while additional causal variants were identified in 54/136 (39.7%) of probands carrying two variants. Seven novel DIVs and six novel non-canonical splice site variants were detected in a total of 35 alleles and characterized, including the c.6283-321C>G variant leading to a complex splicing defect. Additionally, four novel CNVs were identified and characterized in five alleles. These results confirm that smMIPs-based sequencing of the complete ABCA4 gene provides a cost-effective method to genetically solve retinopathy cases and that several rare structural and splice altering defects remain undiscovered in STGD1 cases.
Identifiants
pubmed: 37705246
pii: S2666-2477(23)00069-6
doi: 10.1016/j.xhgg.2023.100237
pmc: PMC10534262
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100237Subventions
Organisme : NEI NIH HHS
ID : P30 EY019007
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028203
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028954
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029315
Pays : United States
Informations de copyright
Copyright © 2023. Published by Elsevier Inc.
Références
Am J Hum Genet. 2000 Oct;67(4):960-6
pubmed: 10958761
Genes (Basel). 2019 Jun 14;10(6):
pubmed: 31197102
J Lipid Res. 2010 Feb;51(2):247-61
pubmed: 19666736
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4249-4256
pubmed: 31618761
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Am J Hum Genet. 2022 Mar 3;109(3):498-507
pubmed: 35120629
Genet Med. 2019 Oct;21(10):2336-2344
pubmed: 30926958
Hum Mutat. 2019 Dec;40(12):2365-2376
pubmed: 31397521
Am J Ophthalmol. 1988 Apr 15;105(4):417-8
pubmed: 3358435
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3220-3231
pubmed: 29971439
Genet Med. 2019 Aug;21(8):1751-1760
pubmed: 30643219
Hum Mol Genet. 2014 Dec 20;23(25):6797-806
pubmed: 25082829
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33924840
Ophthalmology. 2015 Feb;122(2):326-34
pubmed: 25312043
Genet Med. 2020 Jul;22(7):1235-1246
pubmed: 32307445
Hum Mutat. 2015 Jan;36(1):39-42
pubmed: 25346251
Hum Mutat. 2017 Apr;38(4):400-408
pubmed: 28044389
Genome Res. 2018 Jan;28(1):100-110
pubmed: 29162642
Invest Ophthalmol Vis Sci. 2022 Apr 1;63(4):20
pubmed: 35475888
J Med Genet. 2017 Jun;54(6):404-412
pubmed: 28446513
Biochim Biophys Acta. 2009 Jul;1791(7):573-83
pubmed: 19230850
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Prog Retin Eye Res. 2020 Nov;79:100861
pubmed: 32278709
Am J Ophthalmol. 2020 Nov;219:195-204
pubmed: 32619608
Exp Eye Res. 2005 May;80(5):595-606
pubmed: 15862166
Ophthalmology. 2016 Jun;123(6):1375-85
pubmed: 26976702
Nucleic Acids Res. 2001 Mar 1;29(5):1185-90
pubmed: 11222768
J Comput Biol. 1997 Fall;4(3):311-23
pubmed: 9278062
Hum Mutat. 2019 Oct;40(10):1749-1759
pubmed: 31212395
Nucleic Acids Res. 2018 Sep 6;46(15):7913-7923
pubmed: 29750258
Ophthalmology. 2018 Jan;125(1):89-99
pubmed: 28947085
J Biol Chem. 1997 Apr 11;272(15):10303-10
pubmed: 9092582
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Hum Mol Genet. 2021 Jun 26;30(14):1293-1304
pubmed: 33909047
Hum Mol Genet. 2013 Dec 20;22(25):5136-45
pubmed: 23918662
JCI Insight. 2022 Jan 25;7(2):
pubmed: 34874912
Ophthalmology. 2012 Jun;119(6):1199-210
pubmed: 22449572
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Am J Hum Genet. 2018 Apr 5;102(4):517-527
pubmed: 29526278
Genet Med. 2019 Aug;21(8):1761-1771
pubmed: 30670881
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Genet. 1997 Mar;15(3):236-46
pubmed: 9054934
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):394-403
pubmed: 28118664
Hum Mutat. 2022 Dec;43(12):2234-2250
pubmed: 36259723
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590